207 related articles for article (PubMed ID: 32705514)
1. Ipsilateral and Concurrent Breast Cancer and Atypical Ductal Hyperplasia: Does Atypia Also Need Surgical Excision?
Amin AL; Fan F; Winblad OD; Larson KE; Wagner JL
Ann Surg Oncol; 2020 Nov; 27(12):4786-4794. PubMed ID: 32705514
[TBL] [Abstract][Full Text] [Related]
2. Atypical ductal hyperplasia bordering on DCIS on core biopsy is associated with higher risk of upgrade than conventional atypical ductal hyperplasia.
Pawloski KR; Christian N; Knezevic A; Wen HY; Van Zee KJ; Morrow M; Tadros AB
Breast Cancer Res Treat; 2020 Dec; 184(3):873-880. PubMed ID: 32857242
[TBL] [Abstract][Full Text] [Related]
3. Radiologic and Pathologic Features Associated With Upgrade of Atypical Ductal Hyperplasia at Surgical Excision.
Williams KE; Amin A; Hill J; Walter C; Inciardi M; Gatewood J; Redick M; Wick J; Hunt S; Winblad O
Acad Radiol; 2019 Jul; 26(7):893-899. PubMed ID: 30318287
[TBL] [Abstract][Full Text] [Related]
4. Atypia Involving Fibroadenomas: Outcomes and Upgrade Rates.
Aripoli A; Winblad O; Balanoff C; Peterson J; Smith C; Huppe A; Hill M; Wermuth D; Gloyeske N
J Breast Imaging; 2024 May; 6(3):254-260. PubMed ID: 38554256
[TBL] [Abstract][Full Text] [Related]
5. Atypical ductal hyperplasia: breast DCE-MRI can be used to reduce unnecessary open surgical excision.
Bertani V; Urbani M; La Grassa M; Balestreri L; Berger N; Frauenfelder T; Boss A; Marcon M
Eur Radiol; 2020 Jul; 30(7):4069-4081. PubMed ID: 32144463
[TBL] [Abstract][Full Text] [Related]
6. Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia.
Peña A; Shah SS; Fazzio RT; Hoskin TL; Brahmbhatt RD; Hieken TJ; Jakub JW; Boughey JC; Visscher DW; Degnim AC
Breast Cancer Res Treat; 2017 Jul; 164(2):295-304. PubMed ID: 28474262
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic upgrade of atypical ductal hyperplasia of the breast based on evaluation of histopathological features and calcification on core needle biopsy.
Chen LY; Hu J; Tsang JYS; Lee MA; Ni YB; Chan SK; Tse GMK
Histopathology; 2019 Sep; 75(3):320-328. PubMed ID: 31013355
[TBL] [Abstract][Full Text] [Related]
8. Role of vacuum assisted excision in minimising overtreatment of ductal atypias.
McMahon MA; Haigh I; Chen Y; Millican-Slater RA; Sharma N
Eur J Radiol; 2020 Oct; 131():109258. PubMed ID: 32919262
[TBL] [Abstract][Full Text] [Related]
9. Active Surveillance of Atypical Ductal Hyperplasia of the Breast.
Han LK; Hussain A; Dodelzon K; Ginter PS; Towne WS; Marti JL
Clin Breast Cancer; 2023 Aug; 23(6):649-657. PubMed ID: 37328333
[TBL] [Abstract][Full Text] [Related]
10. Upgrade rate of intraductal papilloma diagnosed on core needle biopsy in a single institution.
Lin LH; Ozerdem U; Cotzia P; Lee J; Chun J; Schnabel F; Darvishian F
Hum Pathol; 2021 Apr; 110():43-49. PubMed ID: 33159966
[TBL] [Abstract][Full Text] [Related]
11. Outcome of radial scar/complex sclerosing lesion associated with epithelial proliferations with atypia diagnosed on breast core biopsy: results from a multicentric UK-based study.
Rakha E; Beca F; D'Andrea M; Abbas A; Petrou-Nunn W; Shaaban AM; Kandiyil A; Smith S; Menon S; Elsheikh S; ElSayed ME; Lee AH; Sharma N
J Clin Pathol; 2019 Dec; 72(12):800-804. PubMed ID: 31350292
[TBL] [Abstract][Full Text] [Related]
12. Diagnostic terminology used to describe atypia on breast core needle biopsy: correlation with excision and upgrade rates.
Tozbikian G; George M; Zynger DL
Diagn Pathol; 2019 Jun; 14(1):69. PubMed ID: 31253155
[TBL] [Abstract][Full Text] [Related]
13. High-Risk Lesions Detected by MRI-Guided Core Biopsy: Upgrade Rates at Surgical Excision and Implications for Management.
Michaels AY; Ginter PS; Dodelzon K; Naunheim MR; Abbey GN
AJR Am J Roentgenol; 2021 Mar; 216(3):622-632. PubMed ID: 33439046
[No Abstract] [Full Text] [Related]
14. Long term clinical follow-up of atypical ductal hyperplasia and lobular carcinoma in situ in breast core needle biopsies.
Renshaw AA; Gould EW
Pathology; 2016 Jan; 48(1):25-9. PubMed ID: 27020205
[TBL] [Abstract][Full Text] [Related]
15. Extent and histologic pattern of atypical ductal hyperplasia present on core needle biopsy specimens of the breast can predict ductal carcinoma in situ in subsequent excision.
Wagoner MJ; Laronga C; Acs G
Am J Clin Pathol; 2009 Jan; 131(1):112-21. PubMed ID: 19095574
[TBL] [Abstract][Full Text] [Related]
16. Atypical ductal hyperplasia on core needle biopsy: Development of a predictive model stratifying carcinoma upgrade risk on excision.
Salagean ED; Slodkowska E; Nofech-Mozes S; Hanna W; Parra-Herran C; Lu FI
Breast J; 2019 Jan; 25(1):56-61. PubMed ID: 30461131
[TBL] [Abstract][Full Text] [Related]
17. Surgical upgrade rate of breast atypia to malignancy: An academic center's experience and validation of a predictive model.
Linsk A; Mehta TS; Dialani V; Brook A; Chadashvili T; Houlihan MJ; Sharma R
Breast J; 2018 Mar; 24(2):115-119. PubMed ID: 28833923
[TBL] [Abstract][Full Text] [Related]
18. Is Surgical Excision of Focal Atypical Ductal Hyperplasia Warranted? Experience at a Tertiary Care Center.
Grabenstetter A; Brennan SB; Sevilimedu V; Kuba MG; Giri DD; Wen HY; Morrow M; Brogi E
Ann Surg Oncol; 2023 Jul; 30(7):4087-4094. PubMed ID: 36905438
[TBL] [Abstract][Full Text] [Related]
19. Upgrade Rate of Atypical Ductal Hyperplasia: Ten Years Experience and Predictive Factors.
Gagnon N; Martel E; Cadrin-Chênevert A; Ledoux E; Racicot C; Villiard R
J Surg Res; 2021 Oct; 266():311-318. PubMed ID: 34044175
[TBL] [Abstract][Full Text] [Related]
20. High-risk lesions in the breast diagnosed by MRI-guided core biopsy: upgrade rates and features associated with malignancy.
Cha E; Ambinder EB; Oluyemi ET; Mullen LA; Panigrahi B; Rossi J; Di Carlo PA; Myers KS
Breast Cancer Res Treat; 2022 Dec; 196(3):517-525. PubMed ID: 36242709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
